India Glycols Drops 3% After Four-Day Gain as Investors Assess Demerger Into Three Focused Entities

Quick Take

• India Glycols shares fell approximately 3% after a four-consecutive-day winning streak, as the company prepares for a demerger into three separate focused business entities
• The demerger plan is designed to unlock hidden value by separating India Glycols' chemicals, bio-based ingredients, and other business segments into independent listed companies
• Analysts view the demerger as a long-term value-unlocking event, though near-term profit-taking after the 4-day rally is creating short-term price volatility

India Glycols shares declined approximately 3% in a session of profit-taking following a four-consecutive-day rally driven by investor enthusiasm for the company's announced demerger plan. India Glycols operates across multiple business segments including ethylene oxide derivatives, bio-based chemicals, and specialty ingredients — a diversified structure that has historically caused a conglomerate discount relative to pure-play peers. The demerger into three focused entities is designed to eliminate this discount by allowing each business to trade at valuations appropriate to its sector.

Corporate demergers in India have a strong track record of value creation when the separated entities serve different investor constituencies and can independently access capital markets at better valuations. The comparison benchmark is ITC's demerger of its hotels business, or Reliance's historical restructuring of its communications and energy assets — each creating sector-specific valuation re-rating. For India Glycols, the bio-based chemicals segment is particularly interesting given global demand for sustainable specialty chemicals in personal care, pharmaceuticals, and polymer applications.

Watch India Glycols' National Company Law Tribunal (NCLT) filing for the demerger scheme — the court approval timeline determines when shareholders receive shares in the separated entities. Analyst price target revisions incorporating sum-of-parts valuation for each of the three demerged businesses will quantify the discount-elimination thesis. Foreign investor participation in the bio-based chemicals entity after demerger would be a key signal of global demand for India's sustainable specialty chemicals sector.

Sources: livemint.com

Market news synthesis. Not financial advice. Sources cited above.